股本结构
单位：万股
| 公告日期 | 2026-08-06 | 2026-08-06 | 2026-04-30 | 2026-04-30 | 2026-03-13 | 2026-03-13 |
|---|---|---|---|---|---|---|
| 证券总股本 | 684.80 | 684.38 | 688.13 | 695.16 | 564.37 | 562.86 |
| 普通股本 | 684.80 | 684.38 | 688.13 | 695.16 | 564.37 | 562.86 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-08-04 | 2026-06-30 | 2026-04-28 | 2026-03-31 | 2026-02-28 | 2026-02-27 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-08-06 | 684.80 | 未披露 | 定期报告 | 2026-08-04 |
| 2026-08-06 | 684.38 | 未披露 |
更多>>
From March 31,2026 to June 30,2026
Common stock issued for Employee Stock Purchase Plan
Stock repurchases and retirements
Warrant exercises
|
2026-06-30 |
| 2026-04-30 | 688.13 | 未披露 | 定期报告 | 2026-04-28 |
| 2026-04-30 | 695.16 | 未披露 |
更多>>
From December 31, 2025 to March 31, 2026
Common stock issued for Employee Stock Purchase Plan
Vesting of Restricted Stock Units
Stock-based compensation
Stock repurchases and retirements
|
2026-03-31 |
| 2026-03-05 | 696.84 | 未披露 | 定期报告 | 2026-03-02 |
| 2026-03-13 | 564.37 | 未披露 | 定期报告 | 2026-02-28 |
| 2026-03-13 | 562.86 | 未披露 | 定期报告 | 2026-02-27 |
| 2026-03-05 | 708.67 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Warrant exercises
Common stock issued for Employee Stock Purchase Plan
Common stock issued for acquisition
Debt conversion to common stock
Vesting of Restricted Stock Units
Stock-based compensation
Stock repurchases and retirements
|
2025-12-31 |
| 2025-11-18 | 707.19 | 未披露 | 定期报告 | 2025-11-10 |
| 2025-11-19 | 690.53 | 未披露 |
更多>>
From June 30, 2025 to September 30,2025
Common stock issued for Employee Stock Purchase Plan
Common stock issued for acquisition
Stock-based compensation
|
2025-09-30 |
| 2025-11-18 | 659.51 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Common stock issued for Employee Stock Purchase Plan
Debt conversion to common stock
Stock-based compensation
Vesting of Restricted Stock Units
|
2025-06-30 |
| 2025-06-02 | 555.51 | 未披露 | 定期报告 | 2025-05-22 |
| 2025-11-18 | 598.78 | 未披露 | 定期报告 | 2025-05-12 |
| 2025-04-30 | 556.57 | 未披露 | 定期报告 | 2025-04-23 |
| 2025-11-18 | 595.05 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Common stock issued for Employee Stock Purchase Plan
Vesting of Restricted Stock Units
Stock-based compensation
|
2025-03-31 |
| 2025-03-31 | 552.84 | 未披露 | 定期报告 | 2025-03-24 |
| 2025-03-31 | 551.15 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Common stock issuance for Securities Purchase Agreement
Warrant exercises
Common stock received in sale of business
Common stock issued for Employee Stock Purchase Plan
Common stock issued for acquisition
Debt conversion to common stock
Vesting of Restricted Stock Units
Reverse stock split adjustment
Stock-based compensation
|
2024-12-31 |
| 2024-11-07 | 543.70 | 未披露 | 定期报告 | 2024-11-04 |
| 2024-11-07 | 521.57 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Common stock issued for acquisition
Warrant exercises
Stock-based compensation
Common stock issued for Employee Stock Purchase Plan
|
2024-09-30 |
| 2024-08-08 | 506.57 | 未披露 | 定期报告 | 2024-08-05 |
| 2024-06-27 | 490.00 | 未披露 |
更多>>
1-for-10 reverse stock split of its common stock
|
2024-07-03 |
| 2024-06-27 | 4900.00 | 未披露 | 定期报告 | 2024-06-27 |
| 2024-05-09 | 4971.94 | 未披露 | 定期报告 | 2024-05-06 |
| 2024-04-30 | 4971.97 | 未披露 | 定期报告 | 2024-04-22 |
| 2024-05-09 | 4971.94 | 未披露 |
更多>>
1-for-15 reverse stock split of its common stock
|
2024-04-10 |
| 2024-05-09 | 74542.69 | 未披露 | 定期报告 | 2024-04-09 |
| 2024-04-05 | 74500.00 | 未披露 | 定期报告 | 2024-04-05 |
| 2024-03-29 | 74542.69 | 未披露 | 定期报告 | 2024-03-25 |
| 2024-01-24 | 74523.21 | 未披露 |
更多>>
Common stock offered 66,666,666 shares by the company
|
2024-01-25 |
| 2024-01-24 | 67856.55 | 未披露 | 定期报告 | 2024-01-22 |
| 2024-03-29 | 67667.99 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Common stock issued for Employee Stock Purchase Plan
Common stock issued for acquisition
Common stock issued for exercise of warrants
Common stock issued to Apollo Medical Holding Inc.
Stock-based compensation
Debt conversion to common stock
|
2023-12-31 |
| 2023-11-09 | 67078.16 | 未披露 | 定期报告 | 2023-11-06 |
| 2023-11-09 | 67071.17 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Common stock issued for acquisition
Debt conversion to common stock
|
2023-09-30 |
| 2023-08-09 | 66189.79 | 未披露 | 定期报告 | 2023-08-07 |
| 2023-08-09 | 66074.26 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Common stock issued for exercise of warrants
Debt conversion to common stock
Restricted stock awards issued for compensation
|
2023-06-30 |
| 2023-06-26 | 66074.26 | 未披露 | 定期报告 | 2023-06-16 |
| 2023-05-15 | 65656.32 | 未披露 | 定期报告 | 2023-05-12 |
| 2023-05-19 | 65384.24 | 未披露 | 定期报告 | 2023-04-28 |
| 2023-04-12 | 65214.38 | 未披露 | 定期报告 | 2023-04-06 |
| 2023-03-03 | 65092.61 | 未披露 | 定期报告 | 2023-03-02 |
| 2023-03-03 | 65022.38 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Common stock issued for exercise of options
Reverse acquisition with Clinigence
Notes payable converted to common stock
Common stock issued for exercise of warrants
Equity financing agreement Lincoln Park Capital Fund, LLC
Rescission of warrant exercise
|
2022-12-31 |
| 2022-08-22 | 64977.01 | 未披露 | 定期报告 | 2022-08-22 |
| 2022-08-22 | 64891.85 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Reverse acquisition with Clinigence
Notes payable converted to common stock
Common stock issued for exercise of warrants
Common stock issued for exercise of options
Restricted stock awards issued for compensation
|
2022-06-30 |
| 2022-06-16 | 64741.14 | 未披露 | 定期报告 | 2022-06-15 |
| 2022-05-13 | 64536.15 | 未披露 | 定期报告 | 2022-05-13 |
| 2022-03-31 | 4844.50 | 未披露 | 定期报告 | 2022-04-04 |
| 2022-05-13 | 4846.11 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Notes payable converted to common stock
Exercise of warrants for the issuance of common stock
|
2022-03-31 |
From March 31,2026 to June 30,2026
Common stock issued for Employee Stock Purchase Plan
Stock repurchases and retirements
Warrant exercises
From December 31, 2025 to March 31, 2026
Common stock issued for Employee Stock Purchase Plan
Vesting of Restricted Stock Units
Stock-based compensation
Stock repurchases and retirements
From December 31, 2024 to December 31, 2025
Warrant exercises
Common stock issued for Employee Stock Purchase Plan
Common stock issued for acquisition
Debt conversion to common stock
Vesting of Restricted Stock Units
Stock-based compensation
Stock repurchases and retirements
From June 30, 2025 to September 30,2025
Common stock issued for Employee Stock Purchase Plan
Common stock issued for acquisition
Stock-based compensation
From March 31, 2025 to June 30, 2025
Common stock issued for Employee Stock Purchase Plan
Debt conversion to common stock
Stock-based compensation
Vesting of Restricted Stock Units
From December 31, 2024 to March 31, 2025
Common stock issued for Employee Stock Purchase Plan
Vesting of Restricted Stock Units
Stock-based compensation
From December 31, 2023 to December 31, 2024
Common stock issuance for Securities Purchase Agreement
Warrant exercises
Common stock received in sale of business
Common stock issued for Employee Stock Purchase Plan
Common stock issued for acquisition
Debt conversion to common stock
Vesting of Restricted Stock Units
Reverse stock split adjustment
Stock-based compensation
From June 30, 2024 to September 30, 2024
Common stock issued for acquisition
Warrant exercises
Stock-based compensation
Common stock issued for Employee Stock Purchase Plan
1-for-10 reverse stock split of its common stock
1-for-15 reverse stock split of its common stock
Common stock offered 66,666,666 shares by the company
From December 31, 2022 to December 31, 2023
Common stock issued for Employee Stock Purchase Plan
Common stock issued for acquisition
Common stock issued for exercise of warrants
Common stock issued to Apollo Medical Holding Inc.
Stock-based compensation
Debt conversion to common stock
From June 30, 2023 to September 30, 2023
Common stock issued for acquisition
Debt conversion to common stock
From March 31, 2023 to June 30, 2023
Common stock issued for exercise of warrants
Debt conversion to common stock
Restricted stock awards issued for compensation
From December 31, 2021 to December 31, 2022
Common stock issued for exercise of options
Reverse acquisition with Clinigence
Notes payable converted to common stock
Common stock issued for exercise of warrants
Equity financing agreement Lincoln Park Capital Fund, LLC
Rescission of warrant exercise
From March 31, 2022 to June 30, 2022
Reverse acquisition with Clinigence
Notes payable converted to common stock
Common stock issued for exercise of warrants
Common stock issued for exercise of options
Restricted stock awards issued for compensation
From December 31, 2021 to March 31, 2022
Notes payable converted to common stock
Exercise of warrants for the issuance of common stock